Bimosiamose

Overview

Bimosiamose (TBC-1269) is a nonoligosaccharide pan- selectin antagonist with IC 50 s of 88 μM, 20 μM, and 86 μM for E-selectin , P-selectin , and L-selectin , respectively. Bimosiamose has anti-inflammatory effects.

Application

Products | Products > Disease Areas > Infection | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Coronavirus Infection | Products > Disease Areas > SARS-CoV-2 Infection | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > P-selectin | Products > Signaling Pathways > L-Selectin | Products > Signaling Pathways > E-Selectin

Product Information

• Catalog No.: HY-106139
• CAS No.: 187269-40-5
• Molecular Formula: C46H54O16
• Molecular Weight: 862.91
• Purity: 98.82%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 2.5 mg/mL (2.90 mM); Clear solution
• Availability: In-stock

Source

Original product source